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Abstract
Background: Schwann cells (SCs) are the principal glial cells of the peripheral nervous system with a wide range
of biological functions. SCs play a key role in peripheral nerve regeneration and are involved in several hereditary
peripheral neuropathies. The objective of this study was to gain new insight into the whole protein composition of
SCs.
Results: Two-dimensional liquid chromatography coupled with tandem mass spectrometry (2D LC-MS/MS) was
performed to identify the protein expressions in primary cultured SCs of rats. We identified a total of 1,232
proteins, which were categorized into 20 functional classes. We also used quantitative real time RT-PCR and
Western blot analysis to validate some of proteomics-identified proteins.
Conclusion: We showed for the first time the proteome map of SCs. Our data could serve as a reference library to
provide basic information for understanding SC biology.
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Background
Schwann cells (SCs) are the principal glial cells of the
peripheral nervous system (PNS) with a wide range of
biological functions [1]. Basically, SCs are able to wrap
around the axons of neurons to form compact myelin
sheaths, which allow for rapid and saltatory conduction
of electrical impulses and support the integrity of axons
in the PNS. SCs may also perform functions other than
myelin formation; for example, SCs are involved in
trophic support for neurons, formation of the neural
extracellular matrix, modulation of neuromuscular
synaptic activity, and orchestration of inflammation in
the PNS. Collectively, SCs play a key role in the normal
development and function of the PNS.
After peripheral nerve injury, SCs aid in cleaning up the
tissue debris and guide the regrowth of axons. To accom-
plish this, SCs proliferate to form longitudinal cell strands
known as bands of Bungner, release neurotrophins, and
guide the regenerating axons to target organs. On the
other hand, several hereditary peripheral neuropathies,
such as Charcot-Marie-Tooth disease (CMT), Guillain-
Barré syndrome (GBS), schwannomatosis, and chronic
inflammatory demyelinating polyneuropathy (CIDP), are
probably caused by genetic mutations in SCs, a knowledge
of which is required for the prevention and treatment of
these neuropathies.
Collectively, SC biology has been an active area of neu-
roscience research. As compared to genomic and tran-
scriptomic analysis, the identification of the protein
composition of SCs might be more valuable in examining
the biological characteristics of SCs. Despite some sub-
cellular studies on the proteomic profile of SC mitochon-
dria in the disease state [2], there are few studies dealing
with the comprehensive analysis of cellular proteins in
SCs. In this study, therefore, we aimed to establish a pro-
teome map of primary cultured SCs.
Proteomics strategy represents a powerful tool in the
global investigation of a great multitude of cellular pro-
teins, but the strategy has relied previously on two-
dimensional gel electrophoresis (2-DE), which suffers
from several drawbacks, including labor intensity, limited
dynamic range, and an inability to detect hydrophobic,
alkaline, and low abundance proteins under standard
conditions [3,4]. The gel-based proteomics strategies are
being replaced rapidly by a new proteomics strategy
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mass spectrometry (LC-MS/MS) [5-8], which shows a
high degree of specificity and sensitivity.
By using 2D LC-MS/MS analysis, we identified a total
of 1,232 proteins from primary cultured SCs and accom-
plished functional classification of the identified proteins.
Obviously, the new insight into the protein composition
of SCs not only contributes to the understanding of SC
biology, but also provides an important basis for com-
parative studies between normal and diseased SCs.
Results
Isolation and characterization of primary cultured SCs
For isolation and purification of SCs in vitro, we adopted
efficient procedures to eliminate contamination of fibro-
blasts. The light micrograph demonstrated the typical
morphology of primary cultured SCs (Figure 1A). The
purity of primary cultured SCs was confirmed by flow
cytometry data (Figure 1B), which indicated that 98.56% of
the cell population was S100 b-positive (S100 b protein
serving as a SCs marker). Immunocytochemistry with
anti-S100 b and anti-GFAP provided further evidence for
cell purity (Figure 1C and 1D).
Identification, functional category, and subcelluar
localization of cellular proteins in SCs
According to the criteria for protein identification, as
mentioned in Materials and Methods, more than 700
proteins were identified in each independent biological
replicate, and the corresponding false discovery rates
(FDRs) of three individual analyses were less than 1%.
Detailed information on identified peptides and proteins
is provided in Additional file 1. Subsequently, proteins
identified from three independent analyses and proteins
under identical accession number and/or gene symbol
were merged. The total number of proteins identified in
this study was 1,232. Out of 1,232 proteins, 846 were
identified by two or more unique peptides and the
remaining 386 were identified by one unique peptide.
The annotated spectra of proteins identified on the basis
of one unique peptide are provided in Additional file 1.
The Venn diagram (Figure 2) shows that among 1,232
identified proteins, 555 (45%) were shared by all three
experiments, and 271 (22%) were shared by two experi-
ments (Figure 2); thus, 67% of the proteins were identi-
fied by more than one experiment, confirming the good
reproducibility of the adopted proteomics platform in
protein identification. Furthermore, the 1,232 identified
proteins were categorized into 20 different classes in
terms of their main biological functions by searching the
UniProt protein knowledge database http://www.uniprot.
org/ and PubMed http://www.ncbi.nlm.nih.gov/pubmed/
(Figure 3A), and the details are provided in Additional
file 1. The identified proteins were further assigned to
various subcellular compartments of SCs using ingenuity
pathway analysis (IPA) software (Figure 3B). The results
of subcelluar localization of the 1,232 proteins are listed
in Additional file 1. It was noted that almost half of the
proteins were located in the cell cytoplasm.
Validation of protein expressions
Out of the total 1,232 proteins, 21 proteins, including
LAMC1, APOE, BAG3, ITGA6, UBQLN1, DYNLRB1,
R H O A ,L A M P 2 ,C T S B ,C A L U ,C A D M 1 ,C O L 1 A 1 ,
CTNNB1, CD9, GMFB, NEXN, ANXA4, ATG5, GFAP,
NGFR and S100 b, were subjected to further validation by
quantitative real time RT-PCR (qPCR), and the mRNA
expression levels of these proteins are shown in Figure 4.
The other 6 identified proteins, CNP, GFAP, NGFR,
TUBB3, ATG5 and NEFM, were validated by Western
blot analysis (Figure 5). Among these 6 proteins, 3 pro-
teins, TUBB3, ATG5 and NEFM, were further subjected
to immunocytochemistry (Figure 6).
In all the validated proteins, GFAP, NGFR and S100 b
are markers of SCs [9]; LAMC1, APOE, CTNNB1, CD9,
CNP, and ITGA6 have been reported to be expressed in
SCs [10-16]; but the existence of other proteins in SCs
has been little reported to our knowledge.
Materials and methods
Cell culture
The rat SCs were harvested as previously described [17]
with minor modifications. Briefly, sciatic nerves were har-
vested from Sprague-Dawley rats (1 to 3 d- old) and
enzymatically dissociated by incubation at 37°C sequen-
tially with 1% collagenase and 0.125% trypsin for 30 and
10 min, respectively. The mixture was triturated, centri-
fuged and resuspended in 10% FBS in DMEM. The cell
pellets were plated on poly-L-lysine precoated dishes (35
mm) for incubation in the same medium. On the follow-
ing day, 10 μM cytosine arabinoside was added and
allowed to incubate for an additional 48 h to remove
fibroblasts. The cell culture was maintained subsequently
in DMEM supplemented with 10% FBS, 2 μM forskolin
(Sigma, St Louis, MO) and 2 ng/ml heregulin (HRG,
Sigma) to stimulate SC proliferation. For further purifica-
tion, the cell culture was gently trypsinized, pelleted, and
incubated with anti-Thy1 antibody (AbD Serotec,
Raleigh, NC) on ice for 2 h, followed by incubation in
complement (Jackson Immuno, West Grove, PA) for an
additional 2 h. All media and supplements were bought
from Gibco-Invitrogen (Carlsbad, CA).
Immunocytochemistry
After isolation and purification, primary cultured SCs were
subjected to immunocytochemistry with anti-S100b, anti-
GFAP, anti-TUBB3, anti-NEFM or anti-ATG5. Briefly, the
cell culture was fixed in 4% paraformaldehyde (pH 7.4) for
Shen et al. Proteome Science 2012, 10:20
http://www.proteomesci.com/content/10/1/20
Page 2 of 930 min, permeabilized with 0.3% Triton X-100, 10% goat
serum in 0.01 M phosphate buffered saline (pH 7.2) for 60
min at 37°C, and allowed to incubate with anti-S100b,a n t i -
GFAP (1:200, Abcam, Cambridge, MA), anti-ATG5 (1:200,
Abgent INC, San Diego, CA) and anti-TUBB3, anti-NEFM
(1:200, Sigma) antibody respectively at 4°C overnight, fol-
lowed by reaction with FITC- or PE-conjugated goat anti-
rabbit IgG (1:400, Molecular probes, the Netherlands) for 2
h at room temperature, respectively. The cells were also
stained with 5 μg/ml Hoechst 33342 dye at 37°C for 10 min.
The fluorescence was visualized under a TCS SP5 confocal
microscope (Leica Microsystems, Wetzlar, Germany).
Flow cytometry
For flow cytometric analysis (FCA), primary cultured SCs
were dissociated by treatment with 0.125% (w/v) trypsin,
and the cell pellets were resuspended in a fixation medium
(Invitrogen, Carlsbad, CA) and incubated for 15 min at
room temperature. Permeabilization Medium (Invitrogen,
Carlsbad, CA) and the recommended volume of the anti-
S100b antibody were added (Abcam, Cambridge, MA) to
allow incubation for 20 min. Cells were then stained with
CFTM488A IgG secondary antibodies (Biotium, Hayward,
California) at room temperature for 30 min. Flow cyto-
metric acquisition and data analysis were performed with
a flow cytometer and cellquest software (BD FACScalibur,
BD Bioscience, San Jose, CA). As a negative control, the
cells were incubated only with the FITC-conjugated sec-
ondary antibody. Three independent flow cytometric
experiments were performed.
Sample preparation
Cell cultures were washed with ice-cold phosphate buf-
fered saline (PBS) and lysed in a buffer containing
Figure 1 Characterization of primary cultured SCs. (A) Typical cell morphology of primary cultured SCs under phase-contrast microscopy
(magnification 400×). (B) Representative flow cytometric analysis (FCA) data showing 98.56% of cell population was S100 b-positive. (C) S100 b
(green color) immunocytochemistry combined with Hoechst 33342 staining (blue color) of primary cultured SCs. (D) GFAP (red color)
immunocytochemistry combined with Hoechst 33342 staining (blue color) of primary cultured SCs.
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30 mM sodium pyrophosphate, 50 mM NaF, 0.1 mM
Na3VO4, 1% (v/v) Triton X-100, 1 mM PMSF, and a
protease inhibitor mixture tablet (Roche Applied
Science, Mannheim, Germany). Lysates were clarified by
centrifugation at 15,000 × g for 20 min at 4°C, and pro-
tein concentration was determined by Bradford protein
assay (Bio-Rad, Richmond, CA).
Digestion, sample cleaning, and desalting
Protein from primary cultured SCs was precipitated with
ice-cold acetone overnight at -20°C, and pellets were
dissolved, denatured, alkylated and digested with trypsin
(1:20, w/w, Sigma) at 37°C for 18 h. Prior to on-line 2D
nano LC/MS/MS analysis, samples were cleaned and
desalted. A cation exchange cartridge system (Applied
Biosystems, Foster city, CA) was used to remove the
reducing reagent, SDS, undigested proteins, and trypsin
i nt h es a m p l em i x t u r eb e c a use these materials would
interfere with the LC/MS/MS analysis. Subsequently, the
eluate of cation exchange was desalted on a 4.6-mm-
inner diameter × 150-mm C18 reversed-phase column
(5 μm, 80 Å; Agilent, Waldbronn, Germany).
On-line 2D nano LC/MS/MS
2D nano LC/MS/MS analyses were conducted on a nano-
HPLC system (Agilent, Waldbronn, Germany) coupled to
a hybrid Q-TOF mass spectrometer (QSTAR XL,
Applied Biosystems) equipped with a nano-ESI source
(Applied Biosystems) and a nano-ESI needle (Picotip,
FS360-50-20; New Objective Inc., Woburn, MA). Ana-
lyst™ 1.1 software was used to control the QSTAR XL
mass spectrometry and nano-HPLC system and to
acquire mass spectra. Vacuum-dried peptides were
reconstituted in phase A and injected at a flow rate of
10 μl/min onto a high resolution strong cation exchange
(SCX) column (Bio-SCX, 300-μm inner diameter ×
35 mm; Agilent, Wilmington, DE), which was on line
with a C18 precolumn (PepMap, 300-μm inner diameter ×
5 mm; LC Packings). After loading, the SCX column and
C18 precolumn were flushed with a 16-step gradient
sodium chloride solution (0, 10, 20, 30, 40, 50, 60, 70, 80,
90, 100, 125, 150, 200, 300, and 400 mM) for 5 min and
phase A for 10 min at a flow rate of 15 μl/min. Afterwards,
the precolumn was switched on line with a nanoflow
reversed-phase column (VYDAC 218MS, 75-μm inner dia-
meter × 100 mm; Grace, Hesperia, CA), and the peptides
concentrated and desalted on the precolumn were sepa-
rated using a 120-min linear gradient from 12 to 30% (v/v)
phase B (0.1% (v/v) FA in acetonitrile) at a flow rate of
400 nl/min.
The Q-TOF instrument was operated in a positive ion
mode with ion spray voltage typically maintained at
2.0 kV. A mass spectrum of the sample was acquired in
an information-dependent acquisition mode. The analyti-
cal cycle consisted of a 0.7-s MS survey scan (400-1600
m/z) followed by three 2-s MS/MS scans (100-2000 m/z)
of the three most abundant peaks (i.e.p r e c u r s o ri o n s ) ,
which were selected from the MS survey scan. Precursor
ion selection was based upon ion intensity (peptide signal
intensity above 25 counts/s) and charge state (2+ to 4+),
and once the ions were fragmented in the MS/MS scan,
they were allowed one repetition before a dynamic exclu-
sion for a period of 120 s. Under collision-induced disso-
ciation (CID), fragment ions of the peptides were
produced, resulting in sequencing of the peptides and
identification of the corresponding proteins. External
calibration of mass spectrometer was carried out routi-
nely using reserpine and trypsinized bovine serum
albumin.
Protein identification
The complete set of raw data files (*.wiff) of each run
were uploaded to ProteinPilot software 3.0 (Applied Bio-
systems) and searched against the non-redundant Inter-
national Protein Index (IPI) rat sequence database
(version 3.62, 39,867 entries). The search parameters
were as follows: trypsin digestion; methyl methane thio-
sulfate alkylation of cysteine residue, instrument, QSTAR
ESI; identification focus, biological modifications, and
FDR analysis selected. ProteinPilot uses Paragon algo-
rithm for peptide identification and ProGroup algorithm
to assemble the peptide evidence from the Paragon algo-
rithm to find the smallest number of proteins that could
explain all the fragmentation spectral evidence. Protein
identification is based on the Unused ProtScore score,
which is a measurement of all the peptide evidence for a
Figure 2 The Venn diagram showing the overlap in protein
identification among three independent proteomic analyses (I-
III), which identified 796, 923, and 894 proteins, respectively.
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tein. In this study, the identification of a protein was
reported for unique peptides with an “unused” confi-
dence threshold (ProtScore) of > 1.3%, and with a corre-
sponding FDR of less than 1%.
Functional category and localization of identified proteins
To obtain an overview of their biological significance,
the identified proteins were categorized according to
their main biological functions collected from the Uni-
prot protein knowledge database and PubMed. The
Figure 3 Protein ontology. Identified proteins were classified according to their biological functions (A) and subcellular localization (B).
Shen et al. Proteome Science 2012, 10:20
http://www.proteomesci.com/content/10/1/20
Page 5 of 9localization of the proteins was analyzed by Ingenuity
pathway analysis (IPA, http://www.ingenuity.com).
qPCR
Total RNA was extracted from the primary cultured SCs
using Trizol (Invitrogen), and cDNA was synthesized
from the total RNA using the SuperScript First-Strand
Synthesis System (Invitrogen). The qPCR was conducted
by FastStart
® SYBR Green qPCR Master Mix (Roche,
Germany) according to the manufacture’s specifications.
A 50-μl reaction consisted of 1 μl of cDNA, 25 μlo f2×
Fast SYBR Green Master Mix, 1 μl of each primer, and
22 μl of RNase/DNase free water. Two-step fast cycling
protocol was used in StepOne™ Real-Time PCR System
Figure 4 Validation by qPCR. Histogram showing the mRNA expression level of LAMC1, APOE, BAG3, ITGA6, UBQLN1, DYNLRB1, RHOA, LAMP2,
CTSB, CALU, CADM1, COL1A1, CTNNB1, CD9, GMFB, NEXN, ANXA4, ATG5, GFAP, NGFR and S100 b, relative to that of GAPDH, in primary cultured
SCs, as determined by qPCR.
Figure 5 Validation by Western blot analysis. The representative Western blot image showing the protein expression of NGFR, GFAP, TUBB3,
CNP, ATG5 and NEFM in primary cultured SCs. Equivalent amounts of protein were loaded per gel. GAPDH was used as the protein loading
control for each blot.
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the software supplied by the vendor (Applied Biosys-
tems). Primer sequences are reported in Additional file
2.
Western blot analysis
Cell proteins were extracted from primary cultured SCs
and quantified by a BCA kit. Samples containing 15 μg
of total protein were separated by 12% (w/v) SDS-PAGE
and transferred to a PVDF membrane (Millipore, Bed-
ford, MA). After incubation for 1 h in 5% (w/v) nonfat
milk in TBS-T buffer, the membrane was probed with
the indicated primary antibodies overnight at 4°C. After
wash with TBS-T, the membrane was incubated with
IRDye 800-Conjugated secondary antibodies (Odyssey)
for 1 h at room temperature. The images were scanned
with the GS800 densitometer scanner (Bio-Rad, Her-
cules, CA). The primary antibodies used were rabbit
polyclonal antibody against CNP or GFAP (Bioworld
Technology Inc. Louis Park, MN), rabbit polyclonal
antibody against NGFR (Abcam UK), goat polyclonal
antibody against TUBB 3, mouse monoclonal antibody
against NEFM (Sigma), and rabbit polyclonal antibody
against ATG5 (Abgent, San Diego, CA).
Statistical analysis
Data are presented as the mean ± S.D. Data comparison
was performed by unpaired Student’s t-test with
SPSS10.0 software. Statistical significance was set at p <
0.05. Unless otherwise specified, all assays were con-
ducted at least in triplicate.
Discussion
There have been several proteomic studies concerning
the central nervous system (CNS), providing us with
considerable information in the field of neuroproteomics
[18-28]. In contrast, SCs, as one of the key components
in the PNS, have received little research attention from
the perspective of proteomics. A pioneer study accom-
plished proteome analysis of PNS myelin, which, formed
Figure 6 Validation by immunocytochmistry. Light micrographs, taken by a TCS SP5 confocal microscope equipped with a 63 × oil
immersion lense, showed that (A) primary culture of SCs were immunostained by antibodies against ATG5 (green color), NEFM (red color), or
TUBB3 (green color), respectively; (B) the cell nuclei were stained by Hoechst 33342 (blue color); (C) the merge of (A) and (B); and (D) the views
at a much higher magnification of one cell each per antigen. Scale bar as indicated in the images.
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molecularly specialized plasma membrane extended
from SCs [29]. This study focused on the large-scale
proteomics analysis of SCs themselves, which has hardly
been reported before.
Metabolism-related proteins represented the largest
class (22.8%) of proteins expressed in SCs. For example,
APOE (apolipoproteinE), a lipid metabolism-related pro-
tein, has been shown to protect mice from chronic
inflammatory demyelinating polyneuropathy by affecting
the antigen-presenting function of SCs [11], and to ben-
efit axonal reconstruction and myelin membranes [30].
It follows that this type of protein is responsible for
some of the biological characteristics of SCs.
Other identified proteins are respectively related to a
wide range of functions, including transportation
(13.1%), transcription and translation (9.7%), cytoskele-
ton (7.0%), signal transduction (4.8%), cell adhesion
(4.1%), oxidation reduction (3.9%), chaperone (3.4%),
apoptosis (3.1%), cell cycle and division (3.0%), neuro-
genesis and development (2.8%), cell differentiation and
proliferation (2.5%), immune and inflammatory response
(2.4%), cell growth and migration (1.0%), ECM and
ECM related (0.9%), autophagy and autophagy related
(0.8%), axon and synapse related protein (0.6%), and cell
markers (0.3%). In addition, we also found several pro-
teins with miscellaneous (1.3%) or uncharacterized
(12.6%) functions.
Intriguingly, autophagy and autophagy-related proteins
were expressed in SCs. Autophagy, as a catabolic pro-
cess for the autophagosomic-lysosomal degradation of
bulk cytoplasmic contents, is generally activated by con-
ditions of nutrient deprivation, and is also associated
with a diverse array of physiological and pathological
processes, including development, differentiation, infec-
tion, cancer and neurodegeneration [31]. The identifica-
tion of conserved autophagy genes (ATGs) suggests the
existence of autophagy [32], and autophagy upregulation
may assist in curing diseases caused by toxic intracellu-
lar aggregate-prone proteins or may serve as a lifespan
extender in the normal body [33]. Previous studies have
shown that glial cells from neuropathic mice activate
autophagy in response to rapamycin and produce abun-
dant myelin internodes, and that both the ubiquitin-pro-
teasome system and autophagy mediate the trauma-
induced axonal degeneration and the retrieval of nerve
growth factors [34,35]. In this study, we detected a class
of autophagy-related proteins, including ATG3, ATG5,
LAMP1, and UBQLN1, in primary cultured SCs. As is
known, ATG5 protein contributes to inhibiting lethal
Sindbis virus infections of the CNS in mice [36] and is
involved in immune-mediated myelin injury in mice
[37]; disruption of autophagy by mutation of ATG5 or
ATG7 causes neurodegeneration [38]. In our study,
qPCR, Western blot and immunohistochemistry con-
firmed the expression of the ATG5 protein in primary
cultured SCs. Therefore, we assumed that the expres-
sions of ATG5 and other autophagy-related proteins in
SCs might influence the PNS. Another interesting find-
ing of our confirmatory tests is that some proteins gen-
erally considered to be expressed in neurons, such as
TUBB3 (tubulin3 b chain), TUBB2 (tubulin2 b chain),
and NEFM (neurofilament medium polypeptide), were
also present in SCs. Previous studies have reported the
mRNA expression of NEFM and tubulin in SCs and
TUBB3 expression in neurofibroma SCs [39,40]. To a
certain degree, our results provided further evidence for
these previous studies.
Conclusion
In this study, the 2D LC/MS/MS approach illustrated
t h ep r o t e o m em a po fp r i m a r yc u l t u r e dS C s .W ei d e n t i -
fied a total of 1,232 proteins, among which, 846 were
identified by two or more unique peptides while the
remaining 386 were detected by one unique peptide.
Our data could be used as a reference library to provide
basic information for studying SC biology.
Additional material
Additional file 1: The protein list of three independent experiments,
biological function categories and subcellular localization of 1,232
proteins, and annotated spectra of proteins identified on the basis
of one unique peptide spectrum. Unused (ProtScore): a measurement
of the protein confidence for a detected protein, calculated from the
peptide confidence for peptides from spectra that have not already been
completely “used” by higher scoring winning proteins. Total (ProtScore):
a measure of the total amount of evidence for a detected protein. %
Cov (95): The percentage of matching amino acids from identified
peptides having confidence greater than or equal to 95 divided by the
total number of amino acids in the sequence. (From Proteinpilot online
help).
Additional file 2: The 22 primer sequences used in qPCR.
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